CardiAMP™ Cell Therapy for Heart Failure Trial
Trial details
- Registry ID
- NCT02438306
- Drugs studied
- Autologous cell therapy, Sham
TrialRedline tracks 1 clinical trial sponsored by BioCardia, Inc.: 1 Phase 3.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| CardiAMP™ Cell Therapy for Heart Failure TrialNCT02438306 | Autologous cell therapy, Sham | Completed | 2025-02Actual |
Names as written in the registry records.